Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewPhase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems.Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors.Silencing of UCHL1 by CpG promoter hyper-methylation is associated with metastatic gastroenteropancreatic well-differentiated neuroendocrine (carcinoid) tumors.Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumorsA Hereditary Form of Small Intestinal Carcinoid Associated With a Germline Mutation in Inositol Polyphosphate Multikinase.Ampullary neuroendocrine tumor diagnosed by endoscopic papillectomy in previously confirmed ampullary adenoma.Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs).Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.Survival outcomes and surgical intervention of small intestinal neuroendocrine tumors: a population based retrospective study.Evolving treatment strategies for management of carcinoid tumors.The 2010 WHO classification of digestive neuroendocrine neoplasms: a critical appraisal four years after its introduction.The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors.Treatment Strategies for Metastatic Neuroendocrine Tumors of the Gastrointestinal Tract.Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.Principles of diagnosis and management of neuroendocrine tumours.Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.Expression profiling of small intestinal neuroendocrine tumors identifies subgroups with clinical relevance, prognostic markers and therapeutic targets.Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs.Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria.The North American Neuroendocrine Tumor Society Consensus Guidelines for Surveillance and Medical Management of Midgut Neuroendocrine Tumors.Challenges Staging Neuroendocrine Tumors of the Pancreas, Jejunum and Ileum, and Appendix.Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms.The Added Diagnostic Value of 18F-Fluorodihydroxyphenylalanine PET/CT in the Preoperative Work-Up of Small Bowel Neuroendocrine Tumors.Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.Prognostic and predictive role of the PI3K-AKT-mTOR pathway in neuroendocrine neoplasms.IMP3 expression in small-intestine neuroendocrine neoplasms: a new predictor of recurrence.Impact of (68)Ga-DOTATATE PET/CT on the surgical management of primary neuroendocrine tumors of the pancreas or ileum.
P2860
Q26768483-99968726-A4A5-4CC8-A928-E60DF3B6ED14Q33438326-40B71500-1E78-440C-856A-A68A6FF85814Q33656484-07CA91EA-B8C8-4989-AB2C-C8E3D6BFD8CDQ34452319-2C44645C-9243-454B-A493-2591387A3354Q35229834-CFE69283-34BC-447E-9B55-AF13C193C108Q35486383-B90197AB-59EF-411F-A6F6-5AD01AC738B5Q35599795-39315ECD-97EF-4FF8-813C-18013ED529A1Q36747555-87822B9A-72B9-493A-991E-F49689C515C0Q36875101-EDC27157-A30A-48CF-A606-BCB8CBF4554EQ37531108-E4246812-5532-41B7-AA6E-2B92DFA4CEF2Q37706277-69E2200F-5EAC-4951-BE01-8475E9954C42Q38124702-122CBB09-084A-4BAA-8240-CAF9A998B0B4Q38202029-5953269F-7AFE-4F8D-8FD0-99E36920BD3AQ38441413-FBB64BAA-578C-4BF9-BB19-B104B2D639F4Q38746782-21A57C39-3F03-48A7-9AE5-AD175F66717FQ38996135-3623B48F-F8E4-47B0-BADE-ED775148DA6DQ39225250-2BE0E736-C4DB-48E7-9729-86FCBFCD2850Q39339291-6A89C8F9-6535-4618-915C-5CC7FBF709A7Q39930415-C3703949-ED13-4E72-8CFA-544C9C53A270Q40094521-402B5C5F-82CA-4587-AA0A-90335EBD0CDCQ40277799-4B2CBBA2-1948-4C66-880A-DE5DA7CB9074Q46141893-2295E49B-CD96-4460-B7A3-CE24A62C5516Q46919027-C41F9604-DF43-4B17-B749-59B3304B2E78Q47218406-B79EDC55-0C31-4127-B2B3-71B3FDE49BAFQ47319849-A9963759-6484-44BE-B57E-B17B67FD5006Q47765091-C02D486B-5339-400F-88BF-60E5FE732DD4Q47847243-CA201957-717A-4655-89CD-B01000AA1305Q48224937-2A6C8859-42E6-44FC-A326-A0D320960B61Q50636235-E9F10783-76CE-4672-877E-6558A5F52949
P2860
Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@en
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@nl
type
label
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@en
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@nl
prefLabel
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@en
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@nl
P2093
P356
P1476
Prognostic validity of the Ame ...... midgut neuroendocrine tumors.
@en
P2093
Jill M Weber
Jonathan R Strosberg
Kenneth Meredith
Larry K Kvols
Max Feldman
P304
P356
10.1200/JCO.2012.44.5924
P407
P577
2012-12-17T00:00:00Z